Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03269435 · ClinicalTrials.gov registry record · Phase 4
Greater Occipital Nerve Block Versus Metoclopramide
A Phase 4 study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 99
- Enrollment target
NCT03269435 is a Phase 4 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 99 participants.
The verdict
NCT03269435, a Phase 4 study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 99 participants
- Enrollment target
Study Summary
We are comparing a type of nerve block called greater occipital nerve block versus standard therapy among patients who present to an emergency department for acute migraine. This is a randomized, double-blind, double dummy study. The greater occipital nerve block will be performed bilaterally with bupivacaine 0.5%. Standard therapy is metoclopramide 10mg IV.
Interventions
- DRUG Metoclopramide
- PROCEDURE Greater occipital nerve block with bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2020-03-21 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03269435
The ClinicalTrials.gov registry entry for NCT03269435 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Metoclopramide is the first listed.
NCT03269435 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03269435 about?
NCT03269435 is a clinical study titled "Greater Occipital Nerve Block Versus Metoclopramide". We are comparing a type of nerve block called greater occipital nerve block versus standard therapy among patients who present to an emergency department for acute migraine. This is a randomized, double-blind, double dummy study. The greater occipital nerve block will be performed bilaterally with b...
What is the current status of trial NCT03269435?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 99 participants. The study started on 2017-11-01. Estimated completion is 2020-03-21.
What interventions are being tested in trial NCT03269435?
The interventions under investigation include: Metoclopramide (DRUG), Greater occipital nerve block with bupivacaine (PROCEDURE).
Who is sponsoring clinical trial NCT03269435?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.